Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I.

Saved in:
Bibliographic Details
Title: Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I.
Authors: Rabbani, Ali1 (AUTHOR) alirabbanii44@gmail.com, Alaei, Mohammadreza2 (AUTHOR), Asl, Samaneh Norouzi3,4 (AUTHOR), Setoodeh, Aria5 (AUTHOR), Shakiba, Marjan6 (AUTHOR), Salehpour, Shadab7 (AUTHOR), Eshraghi, Peyman4,8 (AUTHOR), Salehpour, Omid9 (AUTHOR), Sabzvari, Araz10 (AUTHOR), Kafi, Hamidreza11 (AUTHOR), Jarollahi, Ali12 (AUTHOR)
Source: Scientific Reports. 8/19/2025, Vol. 15 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-16351-4